Xavier J. Fagan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xavier J. Fagan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Lyndell Lp Lim
Centre for Eye Research Australia Royal Victorian Eye and Ear Hospital Melbourne Victoria Australia
3 shared publications - Edmund W. C. Khong
Centre for Eye Research Australia Royal Victorian Eye and Ear Hospital Melbourne Victoria Australia
2 shared publications - Felicia Widyaputri
Department of Ophthalmology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publications Jennifer J. Conn
Department of Diabetes and Endocrinology Royal Melbourne Hospital Melbourne Victoria Australia
2 shared publications- Muhammad Bayu Sasongko
Department of Ophthalmology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publications Salmaan Al‐Qureshi
Medical Retina Unit Royal Victorian Eye and Ear Hospital Melbourne Victoria Australia
2 shared publications
Latest Publications
- 23 December 2024
- Published by Springer Nature in International Ophthalmology
- Vol. 45 (1) , 1-26
Near-infrared imaging retinal diagnostic applications—a review
Objective Near-infrared reflectance (NIR) is a commonly performed noncontact and rapid imaging technique. This paper reviews the clinical applications of NIR for diagnosing and monitoring retinal diseases. Methods A comprehensive search was conducted across the Pubmed database. A total of 105 articles were finally included in this article. Images were acquired from the authors own clinical experience. Results The article describes the imaging utility of NIR for diagnosing and deomonstrating findings in various conditions. These include retinal vascular diseases, age-related macular degeneration (AMD), vitreoretinal interface pathologies, retinal dystrophies, inflammatory chorioretinopathies, phakomatoses, retinal toxicities, photic injury, choroidal cavitary lesions, choroidal neoplasms, and choroidal Vascular Lesions. Conclusion NIR is widely acquired during OCT imaging, and is advantageous at imaging with low illumination levels and through narrow pupils or opaque media. NIR offers valuable information for the diagnosis and follow-up of retinal disease, and is highly recommended to utilize for clinical decision-making in ophthalmology.
- 23 December 2024
- Published by Springer Nature in International Ophthalmology
- Vol. 45 (1) , 1-26
Near-infrared imaging retinal diagnostic applications—a review
Objective Near-infrared reflectance (NIR) is a commonly performed noncontact and rapid imaging technique. This paper reviews the clinical applications of NIR for diagnosing and monitoring retinal diseases. Methods A comprehensive search was conducted across the Pubmed database. A total of 105 articles were finally included in this article. Images were acquired from the authors own clinical experience. Results The article describes the imaging utility of NIR for diagnosing and deomonstrating findings in various conditions. These include retinal vascular diseases, age-related macular degeneration (AMD), vitreoretinal interface pathologies, retinal dystrophies, inflammatory chorioretinopathies, phakomatoses, retinal toxicities, photic injury, choroidal cavitary lesions, choroidal neoplasms, and choroidal Vascular Lesions. Conclusion NIR is widely acquired during OCT imaging, and is advantageous at imaging with low illumination levels and through narrow pupils or opaque media. NIR offers valuable information for the diagnosis and follow-up of retinal disease, and is highly recommended to utilize for clinical decision-making in ophthalmology.
- Open Access
- 19 June 2024
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 52 (7) , 761-773
Progression of diabetic retinopathy in women with pregestational diabetes during pregnancy and postpartum
Background: Diabetic retinopathy (DR) may worsen during pregnancy, but its course in the postpartum remains poorly understood. Understanding the natural history of DR during and after pregnancy can help determine when sight‐threatening DR treatment should be administered.Methods: A prospective longitudinal cohort study recruited pregnant women with pre‐existing type 1 (T1D) or type 2 diabetes from two tertiary Diabetes Antenatal Clinics in Melbourne, Australia. Eye examination results in early pregnancy, late pregnancy, and up to 12‐months postpartum were compared to determine DR changes. Two‐field fundus photographs and optical coherence tomography scans were used to assess DR severity.Results: Overall, 105 (61.4%) women had at least two eye examinations during the observation period. Mean age was 33.5 years (range 19–51); 54 women (51.4%) had T1D; 63% had HbA1c <7% in early pregnancy. DR progression rate was 23.8% (95% CI 16.4–32.6). Having T1D (RR 4.96, 95% CI 1.83–13.46), pre‐existing DR in either eye (RR 4.54, 95% CI 2.39–8.61), and elevated systolic blood pressure (adjusted RR 2.49, 95% CI 1.10–5.66) were associated with increased risk of progression. Sight‐threatening progression was observed in 9.5% of women. Among the 19 eyes with progression during pregnancy, 15 eyes remained stable, three eyes progressed, and only one eye regressed in the postpartum.Conclusions: Nearly 1 in 4 women had DR progression from conception through to 12‐months postpartum; almost half of these developing sight‐threatening disease. DR progression occurring during pregnancy was found to predominantly remain unchanged, or worsen, after delivery, with very few eyes spontaneously improving postpartum.
- 19 June 2024
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 52 (7) , 761-773
Open AccessProgression of diabetic retinopathy in women with pregestational diabetes during pregnancy and postpartum
Background: Diabetic retinopathy (DR) may worsen during pregnancy, but its course in the postpartum remains poorly understood. Understanding the natural history of DR during and after pregnancy can help determine when sight‐threatening DR treatment should be administered.Methods: A prospective longitudinal cohort study recruited pregnant women with pre‐existing type 1 (T1D) or type 2 diabetes from two tertiary Diabetes Antenatal Clinics in Melbourne, Australia. Eye examination results in early pregnancy, late pregnancy, and up to 12‐months postpartum were compared to determine DR changes. Two‐field fundus photographs and optical coherence tomography scans were used to assess DR severity.Results: Overall, 105 (61.4%) women had at least two eye examinations during the observation period. Mean age was 33.5 years (range 19–51); 54 women (51.4%) had T1D; 63% had HbA1c <7% in early pregnancy. DR progression rate was 23.8% (95% CI 16.4–32.6). Having T1D (RR 4.96, 95% CI 1.83–13.46), pre‐existing DR in either eye (RR 4.54, 95% CI 2.39–8.61), and elevated systolic blood pressure (adjusted RR 2.49, 95% CI 1.10–5.66) were associated with increased risk of progression. Sight‐threatening progression was observed in 9.5% of women. Among the 19 eyes with progression during pregnancy, 15 eyes remained stable, three eyes progressed, and only one eye regressed in the postpartum.Conclusions: Nearly 1 in 4 women had DR progression from conception through to 12‐months postpartum; almost half of these developing sight‐threatening disease. DR progression occurring during pregnancy was found to predominantly remain unchanged, or worsen, after delivery, with very few eyes spontaneously improving postpartum.
- Open Access
- 7 June 2022
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 50 (7) , 757-767
Prevalence of diabetic retinopathy in women with pregestational diabetes during pregnancy and the postpartum
Background: Diabetic retinopathy (DR) may be affected by pregnancy. The majority of prevalence data regarding DR in pregnancy predate the advent of contemporary guidelines for diabetes management during pregnancy. This study reports DR prevalence and associated risk factors in women with pregestational diabetes during pregnancy and the postpartum in Australia.Methods: A total of 172 pregnant women with type 1 (T1DM) or type 2 diabetes diagnosed pre‐pregnancy were prospectively recruited from two obstetrics hospitals in Melbourne (November 2017–March 2020). Eye examinations were scheduled in each trimester, at 3‐, 6‐, and 12‐months postpartum. DR severity was graded from two‐field fundus photographs by an independent grader utilising the Airlie House Classification. Sight‐threatening DR (STDR) was defined as the presence of diabetic macular oedema or proliferative DR.Results: Overall, 146 (84.9%) women had at least one eye examination during pregnancy. The mean age was 33.8 years (range 19–51), median diabetes duration was 7.0 years (IQR 3.0–17.0), 71 women (48.6%) had T1DM. DR and STDR prevalence during pregnancy per 100 eyes was 24.3 (95% CI 19.7–29.6) and 9.0 (95% CI 6.1–12.9); while prevalence in the postpartum was 22.2 (95% CI 16.5–29.3) and 10.0 (95% CI 5.4–17.9), respectively. T1DM, longer diabetes duration, higher HbA1c in early pregnancy, and pre‐existing nephropathy were significant risk factors.Conclusions: The prevalence of DR in pregnant women was similar to the non‐pregnant diabetic population in Australia. One in nine participants had STDR during pregnancy and the postpartum, highlighting the need to optimise DR management guidelines in pregnancy given the significant risk of vision loss.
- 7 June 2022
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 50 (7) , 757-767
Open AccessPrevalence of diabetic retinopathy in women with pregestational diabetes during pregnancy and the postpartum
Background: Diabetic retinopathy (DR) may be affected by pregnancy. The majority of prevalence data regarding DR in pregnancy predate the advent of contemporary guidelines for diabetes management during pregnancy. This study reports DR prevalence and associated risk factors in women with pregestational diabetes during pregnancy and the postpartum in Australia.Methods: A total of 172 pregnant women with type 1 (T1DM) or type 2 diabetes diagnosed pre‐pregnancy were prospectively recruited from two obstetrics hospitals in Melbourne (November 2017–March 2020). Eye examinations were scheduled in each trimester, at 3‐, 6‐, and 12‐months postpartum. DR severity was graded from two‐field fundus photographs by an independent grader utilising the Airlie House Classification. Sight‐threatening DR (STDR) was defined as the presence of diabetic macular oedema or proliferative DR.Results: Overall, 146 (84.9%) women had at least one eye examination during pregnancy. The mean age was 33.8 years (range 19–51), median diabetes duration was 7.0 years (IQR 3.0–17.0), 71 women (48.6%) had T1DM. DR and STDR prevalence during pregnancy per 100 eyes was 24.3 (95% CI 19.7–29.6) and 9.0 (95% CI 6.1–12.9); while prevalence in the postpartum was 22.2 (95% CI 16.5–29.3) and 10.0 (95% CI 5.4–17.9), respectively. T1DM, longer diabetes duration, higher HbA1c in early pregnancy, and pre‐existing nephropathy were significant risk factors.Conclusions: The prevalence of DR in pregnant women was similar to the non‐pregnant diabetic population in Australia. One in nine participants had STDR during pregnancy and the postpartum, highlighting the need to optimise DR management guidelines in pregnancy given the significant risk of vision loss.
- 1 December 2020
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 55 (6) , 524-526
Spectral-domain optical coherence tomography features in cases of pre-eclampsia and the relationship with systemic parameters
- 1 December 2020
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 55 (6) , 524-526
Spectral-domain optical coherence tomography features in cases of pre-eclampsia and the relationship with systemic parameters
- 15 May 2019
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 47 (7) , 952-954
Curvilinear branching retinal deposits in acute syphilitic posterior placoid chorioretinitis: A novel pattern on en face optical coherence tomography
- 15 May 2019
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 47 (7) , 952-954
Curvilinear branching retinal deposits in acute syphilitic posterior placoid chorioretinitis: A novel pattern on en face optical coherence tomography
- 4 October 2016
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 45 (2) , 201-203
Primary retinoschisis with vascular changes mimicking neovascularization, illustrated with multimodal imaging
- 4 October 2016
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 45 (2) , 201-203
Primary retinoschisis with vascular changes mimicking neovascularization, illustrated with multimodal imaging
- 1 May 2015
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 43 (4) , 297-299
Fenofibrate and diabetic retinopathy
- 1 May 2015
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 43 (4) , 297-299
Fenofibrate and diabetic retinopathy
- 12 July 2013
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 41 (8) , 817-818
Intravitreal injections: a most recent evidence for best practice – response
- 12 July 2013
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 41 (8) , 817-818
Intravitreal injections: a most recent evidence for best practice – response
- 25 June 2013
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 41 (5) , 500-507
Intravitreal injections: a review of the evidence for best practice
Intravitreal injection is a common procedure performed by ophthalmologists. It is a quick and targeted treatment for a number of ophthalmic conditions. Despite this, the potential to cause serious complications and patient discomfort cannot be ignored. This article presents the level of evidence in the scientific literature supporting common practices such as location of the procedure, anaesthetic choice, sterile procedure techniques, comparison of some common pharmaceutical agents and the use of antibiotics.
- 25 June 2013
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 41 (5) , 500-507
Intravitreal injections: a review of the evidence for best practice
Intravitreal injection is a common procedure performed by ophthalmologists. It is a quick and targeted treatment for a number of ophthalmic conditions. Despite this, the potential to cause serious complications and patient discomfort cannot be ignored. This article presents the level of evidence in the scientific literature supporting common practices such as location of the procedure, anaesthetic choice, sterile procedure techniques, comparison of some common pharmaceutical agents and the use of antibiotics.